DSM265: a novel drug for single-dose cure of Plasmodium falciparum malaria

Standard

DSM265: a novel drug for single-dose cure of Plasmodium falciparum malaria. / Bélard, Sabine; Ramharter, Michael.

In: LANCET INFECT DIS, Vol. 18, No. 8, 08.2018, p. 819-820.

Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

Harvard

APA

Vancouver

Bibtex

@article{7abd5ac1a1f840148e20ec39f36f870a,
title = "DSM265: a novel drug for single-dose cure of Plasmodium falciparum malaria",
keywords = "Antimalarials, Humans, Malaria, Falciparum, Malaria, Vivax, Oxidoreductases Acting on CH-CH Group Donors, Plasmodium falciparum, Pyrimidines, Triazoles",
author = "Sabine B{\'e}lard and Michael Ramharter",
year = "2018",
month = aug,
doi = "10.1016/S1473-3099(18)30374-8",
language = "English",
volume = "18",
pages = "819--820",
journal = "LANCET INFECT DIS",
issn = "1473-3099",
publisher = "Lancet Publishing Group",
number = "8",

}

RIS

TY - JOUR

T1 - DSM265: a novel drug for single-dose cure of Plasmodium falciparum malaria

AU - Bélard, Sabine

AU - Ramharter, Michael

PY - 2018/8

Y1 - 2018/8

KW - Antimalarials

KW - Humans

KW - Malaria, Falciparum

KW - Malaria, Vivax

KW - Oxidoreductases Acting on CH-CH Group Donors

KW - Plasmodium falciparum

KW - Pyrimidines

KW - Triazoles

U2 - 10.1016/S1473-3099(18)30374-8

DO - 10.1016/S1473-3099(18)30374-8

M3 - Other (editorial matter etc.)

C2 - 29909070

VL - 18

SP - 819

EP - 820

JO - LANCET INFECT DIS

JF - LANCET INFECT DIS

SN - 1473-3099

IS - 8

ER -